Ascent Group, LLC Pfizer Inc Transaction History

Ascent Group, LLC

$1.12 Billion
Q1 2024

A detailed history of Ascent Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ascent Group, LLC holds 41,280 shares of PFE stock, worth $1.15 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

41,280

Previous 42,540 2.96%

Holding current value

$1.15 Million

Previous $1.22 Million 6.45%

% of portfolio

0.1%

Previous 0.12%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $32,621 - $37,459	-1,260 Reduced 2.96%	41,280 $1.15 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $209,301 - $271,859	-8,010 Reduced 15.85%	42,540 $1.22 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $570,752 - $667,152	-17,786 Reduced 26.03%	50,550 $1.68 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $119,376 - $138,115	-3,305 Reduced 4.61%	68,336 $2.51 Million
Q1 2023 May 10, 2023	SELL	$39.39 - $51.28 $1.04 Million - $1.35 Million	-26,358 Reduced 26.9%	71,641 $2.92 Million

Q4 2022 Feb 16, 2023	SELL	$41.75 - $54.5 $8,600 - $11,227	-206 Reduced 0.21%	97,999 $5.02 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $180,772 - $220,678	4,131 Added 4.39%	98,205 $4.57 Million
Q2 2022 Aug 05, 2022	BUY	$46.53 - $55.17 $27,080 - $32,108	582 Added 0.62%	94,074 $4.75 Million
Q1 2022 May 10, 2022	SELL	$45.75 - $56.69 $10,110 - $12,528	-221 Reduced 0.24%	93,492 $4.84 Million
Q4 2021 Mar 01, 2022	BUY	$41.32 - $61.25 $3.87 Million - $5.74 Million	93,713 New	93,713 $4.95 Million

Others Institutions Holding PFE

# of Institutions

3,162

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Group, LLC with notifications on news.

Account